Table 1.
Baseline characteristics of the study patients (N = 220).
| Characteristics | N (%) or median (IQR) |
|---|---|
| Age (years) | 49.4 (33.0, 59.4) |
| <29 | 33 (15.0%) |
| 29–39 | 41 (18.6%) |
| 39–49 | 34 (15.5%) |
| ≥49 | 112 (50.9%) |
| Height (cm) | 170.0 (165.0, 174.0) |
| Weight (kg) | 59.0 (53.0, 66.0) |
| BMI (kg/m2) | 20.8 (18.8, 22.5) |
| <18.5 | 43 (19.5%) |
| 18.5–25.0 | 153(69.5%) |
| ≥25.0 | 17 (7.7%) |
| Missing | 7 (3.2%) |
|
| |
| Gender | |
| Male | 197 (89.5%) |
| Female | 23 (10.5%) |
|
| |
| Transmission route | |
| Drug use | 3 (1.4%) |
| Homosexual | 97 (44.1%) |
| Heterosexual | 113 (51.4%) |
| Missing | 7 (3.2%) |
|
| |
| WHO clinical stage | |
| I | 12 (5.5%) |
| II | 63 (28.6%) |
| III | 93 (42.3%) |
| IV | 52 (23.6%) |